FDA
-
-
-
-
-
-
-
Medincell: Videoconference and Publication of Annual Financial Results, Tuesday, June 16, 2026
-
-
-
-
-
-
-
Seaport Therapeutics adds former Intra-Cellular CEO to board
-
-
-
-
-
-
-
Medincell Announces Successful c. €48 Million Private Placement
-
-
-
-
-
-
-
Medincell - UZEDY®: Net Sales Increased from $117M in 2024 to $191M in 2025 (+63%)
-
-
-
-
-
-
-
Medincell Awarded New Grant to Fight Malaria
-
-
-
-
-
-
-
Medincell: FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder
-
-
-
-
-
-
-
Teva to host investor call on olanzapine trial results Sept 22
-
326,977 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

